Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene

Cancer Research

Volumn 60, Issue 20, 2000, Pages 5803-5814

  Ayyanathan, Kasirajan ^a   Fredericks, William J ^a   Berking, Carola ^a   Herlyn, Meenhard ^a   Balakrishnan, Christopher ^a   Gunther, Edward ^a   Rauscher, Frank J ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ESTROGEN RECEPTOR; PROTEIN BCL X; REPRESSOR PROTEIN; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX3 FKHR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FEMALE; GENE REPRESSION; HORMONAL REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NICK END LABELING; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DNA BINDING; RHABDOMYOSARCOMA; SCID MOUSE; TRANSCRIPTION REGULATION; TUMOR REGRESSION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASE SEQUENCE; BCL-X PROTEIN; CELL DIVISION; COS CELLS; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE TARGETING; GENES, REPORTER; HUMANS; LUCIFERASES; MICE; MICE, SCID; MOLECULAR SEQUENCE DATA; ONCOGENES; PAIRED BOX TRANSCRIPTION FACTORS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; RHABDOMYOSARCOMA, ALVEOLAR; TAMOXIFEN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0034667398     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. The role of chimeric paired box transcription factors in the pathogenesis of pediatric rhabdomysarcoma
2. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma
3. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3
4. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma
5. The role of Pax3 and Pax7 in development and cancer
6. The oncogenic potential of Pax genes
7. Transcriptional activation of the bcl-2 apoptosis suppressor gene by the paired box transcription factor PAX8
8. Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease
9. Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins
10. Pax3 functions in cell survival and in pax7 regulation
11. Induction of antisense Pax-3 expression leads to the rapid morphological differentiation of neuronal cells and an altered response to the mitogenic growth factor bFGF
12. Regulation of Pax-3 expression in the dermomyotome and its role in muscle development
13. Abnormal skeletogenesis occurs coincident with increased apoptosis in the Splotch (Sp2H) mutant: Putative roles for Pax3 and PDGFRα in rib patterning
14. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3
15. Muscle differentiation: More complexity to the network of myogenic regulators
16. Tumor-specific PAX3-FKHR transcription factor, but not PAX3, activates the platelet-derived growth factor α receptor
17. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the PAX3-FKHR oncogene
18. Kruppel-associated boxes are potent transcriptional repression domains
19. KAP-1, a novel corepressor for the highly conserved KRAB repression domain
20. 1 arrest induced by interleukin-2 withdrawal
21. Transcriptional repression mediated by the WT1 Wilms tumor gene product
22. Positive and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulator
23. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins
24. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments
25. Hormone-regulatable neoplastic transformation induced by a Jun-estrogen receptor chimera
26. Modulation of c-Myc activity and apoptosis in vivo
27. Design of conditionally active STATs: Insights into STAT activation and gene regulatory function
28. Krab domains analyzed in human Cys/His-type zinc-finger proteins KOX 1, KOX 8, and KOX 19
29. Molecular cloning and characterization of a human PAX-7 cDNA expressed in normal and neoplastic myocytes
30. KAP-1 corepressor protein interacts and colocalizes with heterochromatic and euchromatic HP1 proteins: A potential role for Kruppel-associated box-zinc finger proteins in heterochromatin-mediated gene silencing
31. Differential subtraction display: A unified approach for isolation of cDNAs from differentially expressed genes
32. A microplate assay for quantitation of anchorage-independent growth of transformed cells
33. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene
34. Several regions of human estrogen receptor are involved in the formation of receptor-heat shock protein 90 complexes
35. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy
36. Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR
37. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein
38. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death
39. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents
40. Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma
41. Negative regulation of the forkhead transcription factor FKHR by Akt